ADCT Earnings ADC Therapeutics SA
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–14 of 14
| Q1 2026 | 2026-03-31 | -0.21 | 2026-05-04 | 10-Q |
| FY 2025 | 2025-12-31 | -1.12 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -1.14 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.86 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.36 | 2026-05-04 | 10-Q |
| FY 2025 | 2024-12-31 | -1.62 | 2026-03-10 | 10-K |
| Q3 2025 | 2024-09-30 | -1.35 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.93 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.56 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -2.94 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -1.90 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.33 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.73 | 2024-05-06 | 10-Q |
| FY 2023 | 2022-12-31 | -2.01 | 2024-03-13 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.